News

A New Medical Device to Treat Complex Coronary Disease: A Quebec First for the Montreal Heart Institute

December 15, 2021

The Montreal Heart Institute (MHI) announces that the Hemodynamics Service has performed Quebec’s first intervention using an orbital atherectomy system on a patient. This state-of-the-art medical device dilates severely blocked arteries caused by calcium plaques.

This procedure creates space in the calcified artery for a stent to be installed. This small, expandable tube keeps the artery open and helps the blood flow properly.

Read more

The Montreal Heart Institute Receives $9.35 Million From the Quebec Government to Lead a Major Virtual Clinical Trial Project

December 13, 2021

The Montreal Heart Institute (MHI) announces that it has won a request for proposals from the Fonds d’accélération des collaborations en santé (FACS). Pierre Fitzgibbon, Minister of Economic and Innovation, announced today a $9.35 million grant from the Government of Quebec to develop and deploy the project entitled Paradigm Shift in the Conduct of Clinical Trials.

Read more

Fighting gut infections contributes to preventing Crohn’s disease and ulcerative colitis.

November 11, 2021

A research team from the Montreal Heart Institute (ICM) has shown that genes present in specific intestinal cells protect against the development of inflammatory bowel diseases (IBD). Published today in the scientific journal Genome Medicine, the study results show that more than a dozen of these genes, which contribute to the development of Crohn’s disease and ulcerative colitis, help fight viral and bacterial infections.

Read more